Ascletis Pharma’s $400 Million Initial Public Offering

Michael Patrini Asia & Pacific, Asia & Pacific Legal Chronicle

Paul Hastings advised Morgan Stanley, Goldman Sachs and China Merchant Securities as the joint sponsors in Ascletis Pharma’s US$400 million global offering and Hong Kong IPO,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Michael Patrini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here